Published in Gematol Transfuziol on November 01, 1990
Interphase ribosomal RNA cistron staining in chronic myeloid leukaemia. Clin Mol Pathol (1995) 0.83
Nucleoli and AgNORs in Hodgkin's disease. Mol Pathol (1997) 0.79
Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. Mol Pathol (1997) 0.75
Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours. Mol Pathol (2000) 0.95
Interphase ribosomal RNA cistron staining in chronic myeloid leukaemia. Clin Mol Pathol (1995) 0.83
[Activity of the nucleolar organizers of the cells in epithelial tumors of the human large intestine]. Biull Eksp Biol Med (1986) 0.81
[Evaluation of the nucleolar organizer activity of tumor cells in patients with esophageal and stomach cancers]. Biull Eksp Biol Med (1985) 0.81
The activity of nucleolar organizer regions of human bone marrow cells studied with silver staining. II. Acute leukemia. Cancer Genet Cytogenet (1987) 0.79
[A method of estimating the protein-synthesizing functions of human cardiomyocytes]. Arkh Anat Gistol Embriol (1989) 0.79
[Functional activity of human thyrocytes in diffuse toxic goiter, autoimmune thyroiditis and thyroid nodules using nucleolar silver staining]. Arkh Patol (1994) 0.79
[Characteristics of the silver-stained nucleoli in blast elements of various diameters from patients with acute leukemia]. Tsitologiia (1988) 0.79
[The structure and function of the chromosomal nucleolus organizer regions: the molecular, cytological and clinical aspects]. Tsitologiia (1992) 0.78
Complete or partial trisomy for the long arm of chromosome 1 in patients with various hematologic malignancies. Hum Genet (1983) 0.77
[Elevated expression of argentophilic proteins from the nucleolar organizer regions in myocardium of patients with obstructive hypertrophic cardiomyopathy and mutations in p53 tumor suppressor gene]. Tsitologiia (2003) 0.76
[Activity of the nucleolar organizers in cardiomyocytes of patients with arterial hypertension of varying genesis]. Arkh Patol (1989) 0.76
[Results of the study of the activity of bone marrow nucleolar organizers in patients with multiple myeloma]. Tsitol Genet (1986) 0.76
Combined surgical and immunotherapeutic treatment of patients with fourth stage colon cancer. Hybridoma (1999) 0.76
[Nucleolar organizer activity of normal and leukemic cells in human bone marrow]. Tsitologiia (1984) 0.76
[Determination of nucleolar organizer activity in the differential diagnosis of severe dysplasia and cancer of the large intestine]. Arkh Patol (1992) 0.75
[Activity of nucleolar organizers in megakaryocytes from patients with leukemia]. Gematol Transfuziol (1995) 0.75
[Nature of the silver staining and association of acrocentric chromosomes in normal and leukemic human cells]. Tsitologiia (1986) 0.75
[Megakaryocytopoiesis]. Gematol Transfuziol (1996) 0.75
[Combined study of leukemic blasts using DNA autoradiography and cytophotometry]. Tsitologiia (1978) 0.75
[Analysis of the structural-functional status of nucleoli from cardiomyocytes, fibroblast-like cells and endotheliocytes in patients with familial obstructive hypertrophic cardiomyopathy]. Ter Arkh (2002) 0.75
[A decrease in the activity of the nucleolar organizers of the gastric and duodenal mucosal cells in peptic ulcer patients]. Ter Arkh (1990) 0.75
[Method of study of functional activity of chromosomes of human bone marrow cells]. Lab Delo (1976) 0.75
[Phenomenon of hyperexpression of ribosomic cistrons in bone marrow hemopoietic elements in bronchial asthma]. Ter Arkh (2004) 0.75
[A model of the interclonal interactions in chronic myeloleukemia]. Eksp Onkol (1989) 0.75
[Mitotic activity of cells of the lymphoid and granulocytic elements of the bone marrow in chronic lympholeukemia]. Probl Gematol Pereliv Krovi (1971) 0.75
[A study of mitotic indices and H3-thymidine uptake of bone marrow and blood cells in patients with chronic granulocytic leukemia]. Tsitologiia (1968) 0.75
[Characteristics of ribosomal RNA synthesis in the blood lymphocytes of chronic lympholeukemia patients]. Tsitologiia (1987) 0.75
[Changes in mitotic activity in leukocytic elements in the bone marrow and blood of patients with acute leukosis]. Tsitologiia (1970) 0.75
[Prognostic significance of the activity of nucleolar organizer regions in megakaryocytes from patients with acute lymphoblastic leukemia]. Gematol Transfuziol (1996) 0.75
[Liposomes in experimental virology]. Vopr Virusol (1990) 0.75
[Characteristics of DNA replication of the chromosomes of the bone marrow cells in patients with acute leukemia]. Tsitologiia (1976) 0.75
[Allelic distribution of the CYP1A1 in lung cancer patients, middle-aged tissue donors and in elderly people without cancer]. Vopr Onkol (2004) 0.75
[Characteristics of the silver-stained nucleoli of tumor cells from the pleural fluid of lung cancer patients]. Tsitologiia (1987) 0.75
[An evaluation of the plastic function of the cardiomyocytes by silver staining of the nucleoli in patients operated on for ischemic heart disease]. Arkh Patol (1994) 0.75
[Study of the activity of the nucleolus organizer segments in the chromosomes of normal, leukemic and neoplastic human cells by silver nitrate staining]. Tsitologiia (1980) 0.75
[Specific chromosomal changes (aberrations)--supplementary marker of malignant degeneration in oncomorphologic studies]. Arkh Patol (1986) 0.75
[State of the myocardium in cardiac insufficiency in patients with ischemic heart disease]. Vestn Akad Med Nauk SSSR (1987) 0.75
[Acute lymphoblastic leukemias with translocations (1;19)(q23;p13): a description of 3 new cases and a review of the literature]. Ter Arkh (2010) 0.75
[Clinical and kinetic characteristics of a temporarily nonproliferating subpopulation of bone marrow blast cells from acute leukemia patients (based on data on DNA autoradiography and cytophotometry]. Tsitologiia (1983) 0.75
[The cytogenetics of hemopoietic dysplasias]. Gematol Transfuziol (1988) 0.75
[Complex chromosome damages in patients with recurrent acute leukemias after allogeneic hematopoietic stem cell transplantations]. Ter Arkh (2012) 0.75
[Possibilities of transfusion therapy in surgical practice]. Vestn Khir Im I I Grek (2014) 0.75